Solius

Solius is a startup based in the United States. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.

Solius develops the only FDA-cleared over-the-counter UVB light therapy device that personalizes UVB dosing based on skin tone to safely deliver health benefits of sunlight such as vitamin D synthesis and improved mood.